Welcome to the June 2012 issue of Pharmaceutical Technology Sourcing and Management, Pharmaceutical Technology’s and Pharmaceutical Technology Europe’s information resource on pharmaceutical ingredients, manufacturing, and the supply chain. In this issue, we examine Big Pharma’s key moves in drug development and manufacturing thus far in 2012 and financing trends in the biopharmaceutical industry. Plus novel approaches in catalysis in API manufacturing and advances in nanotechnology and needle-free jet injection systems in drug delivery. And the latest developments from the bio/pharmaceutical industry relating to corporate social responsibility and sustainability.

Global Feature
Big Pharma's Mid-Year Review
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
The key activity of the pharmaceutical majors influencing drug development and manufacturing thus far in 2012.

Biotech
An Uneven Path for Biotech Financing
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Venture-capital funding is up in 2012, but public financing remains sluggish in the biopharmaceutical industry.

Advertisement:

When Softgels Are a Good First Option: Overcoming Bioavailability Challenges
Event Date: June 12, 2012 at 11:00 AM EDT
Register for this FREE WEBCAST!
Click Here

OUTSOURCING
Channeling Steve Jobs
Jim Miller, president of PharmSource Information Services and contributing editor to Pharmaceutical Technology
Service providers must focus on delivering a superior customer experience.

APIs
Seeking Chemocatalytic and Biocatalytic Solutions
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Advances in palladium-catalyzed hydrogenation, visible-light photocatalysis, and chemocatalyisis for heterocycles are some recent developments.

Drug Delivery
Technical Insights: Targeted Drug Delivery
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Needle-free jet injection systems, gold-coated nanoparticles, and elastic capsules with nanosized flakes advance targeted drug delivery.

CSR and SUSTAINABILITY FORUM

CSR and Sustainability in the News
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

Pharma Industry Addresses Global Health Concerns
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Europe and editor of Sourcing and Management
The pharmaceutical industry weighs in on global health initiatives addressed by the World Health Assembly, including R&D for diseases of the developing world, a global vaccine action plan, neglected tropical diseases, and counterfeit medicines.